Abstract |
The failure of adenovirus-mediated gene therapy often derives from the absence of coxsackie and adenovirus receptor (CAR) expression in target cells. We hypothesize that the slight up-regulation of CAR expression might boost the effect of adenovirus-mediated gene therapy in ovarian cancer. To test this hypothesis, we transfected full-length and intracellular-domain-deleted (tailless) CAR plasmids into CAR-deficient ovarian cancer cell line SKOV3. We observed significant elevations of the in vitro killing effect of Adv-TK and oncolytic adenovirus-mediated cytopathic effect (CPE) in transfected sub-clones, and tailless-transfected SKOV3 showed higher CAR expressions than full-length CAR-transfected cells. We conclude that the extracellular domain of CAR is essential for adenovirus-based gene therapy and, furthermore, that its intracellular domain might play an important role in the regulation of its own expression.
|
Authors | Beibei Wang, Gang Chen, Jianfeng Zhou, Peng Wu, Danfeng Luo, Xiaoyuan Huang, Tao Zhu, Zhiqiang Han, Gang Xu, Shixuan Wang, Yunping Lu, Ding Ma |
Journal | Cancer letters
(Cancer Lett)
Vol. 248
Issue 2
Pg. 299-307
(Apr 18 2007)
ISSN: 0304-3835 [Print] Ireland |
PMID | 17166654
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- CLMP protein, human
- Coxsackie and Adenovirus Receptor-Like Membrane Protein
- Receptors, Virus
|
Topics |
- Adenoviridae Infections
(therapy)
- Blotting, Western
- Cell Line, Tumor
- Coxsackie and Adenovirus Receptor-Like Membrane Protein
- Female
- Flow Cytometry
- Gene Expression
- Genetic Therapy
(methods)
- Humans
- In Vitro Techniques
- Ovarian Neoplasms
(virology)
- Receptors, Virus
(chemistry, metabolism)
- Reverse Transcriptase Polymerase Chain Reaction
- Transfection
- Up-Regulation
|